Search

everythinglearnresearchcommunity

for

Search:↓

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Spironolactone treatment increases the amount of testosterone available in the body.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

Medications for PCOS don't seem to raise heart disease risk.